Bicyclic tetrapeptide histone deacetylase inhibitors with methoxymethyl ketone and boronic acid zinc-binding groups

Add time:08/08/2019    Source:sciencedirect.com

Histone deacetylase (HDAC) inhibitors are a class of potential therapeutics for the treatment of cancer. Bicyclic tetrapeptides equipped with methoxymethyl ketone and boronic acid as zinc-binding group were designed and synthesized. The inhibitory activities of these compounds were evaluated against HDAC enzymes. The cell-free and cell-based assay data showed that both potency and selectivity changed with the change in zinc-binding group. Boronic acid-based compound showed poor activity whereas methoxymethyl ketone-based compound displayed impressive activity in both cell-free and cell-based conditions.

We also recommend Trading Suppliers and Manufacturers of 1-(METHOXYMETHYL)-1H-INDOLE-3-CARBOXYLIC ACID (cas 135039-80-4). Pls Click Website Link as below: cas 135039-80-4 suppliers

Prev:Orally bioavailable pyridine and pyrimidine-based Factor XIa inhibitors: Discovery of the methyl N-phenyl carbamate P2 prime group
Next:Experimental and theoretical study of the acylation reaction of aminopyrazoles with aryl and methoxymethyl substituents)